Management of bleeding in a patient with colorectal cancer: a case study.
Superficial bleeding in patients with malignant disease is a distressing symptom, which is often difficult to control. The following is a case study outlining the use of Sucralfate, an oral cytoprotective agent, used topically in a patient with colo-rectal cancer. The treatment resulted in control of bleeding, less localized pain and more freedom and independence for the patient.
Farncombe
M
M
Ottawa Civic Hospital, Ontario, Canada.
D000287:Administration, Topical; D000368:Aged; D015179:Colorectal Neoplasms / Q000150:complications*; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D012002:Rectal Diseases / Q000209:etiology / Q000517:prevention & control*; D013392:Sucralfate / Q000008:administration & dosage*
D013392:Sucralfate